Author
S. C. Short
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2017-2019 · peak 3/yrCo-Author Collaboration Network
10 top collaborators · 30 mutual co-author links5 papers
Recent·Most cited
- Cancer BiologybioRxivPreprint
A high-content screen profiles cytotoxic microRNAs in pediatric and adult glioblastoma cells and identifies miR-1300 as a potent inducer of cytokinesis failure
M. Boissinot, H. King, M. Adams…·S. C. Short
This study identifies miR-1300 as a potent cytotoxic microRNA in glioblastoma cells, causing cytokinesis failure and apoptosis, with potential therapeutic applications.
DOI 10.1101/789438 - Cancer BiologybioRxivPreprint
JARID2 facilitates transcriptional reprogramming in glioblastoma in response to standard treatment
N. Rippaus, A. F-Bruns, G. Tanner…·L. F. Stead
The paper identifies JARID2-mediated transcriptional reprogramming in glioblastoma post-treatment, showing dysregulated genes with JARID2 binding sites are universally altered in recurrent tumors.
DOI 10.1101/649400 - Cancer BiologybioRxiv
Chemically-induced Neurite-like Outgrowth Reveals Multicellular Network Function in Patient-derived Glioblastoma Cells
B. da Silva, E. S. Polson, A. Droop…·H. Wurdak
The paper shows that ROCKi promotes neurite-like outgrowth in GBM cells, forming radiation-resistant multicellular networks that can be reversed.
DOI 10.1242/jcs.228452 - Cancer BiologybioRxiv
The small molecule KHS101 induces bioenergetic dysfunction in glioblastoma cells through inhibition of mitochondrial HSPD1
E. S. Polson, V. B. Kuchler, C. Abbosh…·H. Wurdak
The paper shows KHS101 inhibits HSPD1 in glioblastoma cells, causing metabolic dysfunction and tumor growth reduction without affecting normal cells.
DOI 10.1126/scitranslmed.aar2718